|
JP2021008518A
|
|
SELF-EMULSIFYING COMPOSITION OF ω-3 FATTY ACID
|
|
WO2021060351A1
|
|
Nsaid-bonded alginic acid derivative
|
|
WO2021060395A1
|
|
Sustained-release pharmaceutical composition
|
|
WO2021060336A1
|
|
Novel crosslinked alginic acid structure
|
|
WO2020262642A1
|
|
Transplantation device using chemically crosslinked alginic acid
|
|
WO2021039023A1
|
|
Method for producing heterocyclidene acetamide derivatives
|
|
WO2020105577A1
|
|
Device for attaching sheet in body cavity and method for attaching sheet
|
|
JP2020070294A
|
|
Azole antifungal agent-containing solution
|
|
WO2021038889A1
|
|
Method for producing heterocyclidene acetamide derivative
|
|
WO2020032221A1
|
|
Alginate hollow microfiber
|
|
CA3103227A1
|
|
Novel crosslinked alginic acid
|
|
JP2019147805A
|
|
SELF-EMULSIFYING COMPOSITION OF ω-3 FATTY ACID
|
|
WO2019189717A1
|
|
Method for producing tetrahydronaphthylurea derivative
|
|
WO2019189766A1
|
|
Novel biaryl amide derivative
|
|
EP3778653A1
|
|
Novel reactive alginic acid derivatives
|
|
WO2019189419A1
|
|
Anti-cancer agent-bonded alginic acid derivative
|
|
WO2019182015A1
|
|
Alginic acid derivative bonded to nonsteroidal anti-inflammatory compound
|
|
CN111718293A
|
|
Process for producing bisarylamide derivative
|
|
CA3092253A1
|
|
Novel photocrosslinkable alginic acid derivative
|
|
WO2019167935A1
|
|
Use of anti-cd14 antibody useful for measurement of presepsin
|
